Redwood Wealth Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Redwood Wealth Management Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-745	Closed	-$576K	–	97
2026 Q1	$576K	Sell	745 -10	-1%	-$7.66K	0.25%	84
2025 Q4	$583K	Buy	755 +249	+49%	+$169K	0.24%	83
2025 Q3	$285K	Hold	506	–	–	0.12%	142
2025 Q2	$266K	Buy	506 +23	+5%	+$12.8K	0.12%	147
2025 Q1	$306K	Sell	483 -14	-3%	-$9.63K	0.16%	122
2024 Q4	$354K	Buy	497 +20	+4%	+$16.8K	0.17%	117
2024 Q3	$501K	Sell	477 -50	-9%	-$55.6K	0.25%	90
2024 Q2	$554K	Sell	527 -29	-5%	-$28.1K	0.42%	50
2024 Q1	$535K	Hold	556	–	–	0.57%	52
2023 Q4	$488K	Sell	556 -110	-17%	-$90.6K	0.54%	55
2023 Q3	$548K	Buy	666 +8	+1%	+$6.29K	0.64%	45
2023 Q2	$473K	Buy	658 +318	+94%	+$245K	0.52%	55
2023 Q1	$279K	Buy	+340	New	+$256K	0.32%	93

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

Redwood Wealth Management Group's REGN Position: Q2 2026 in Review

Redwood Wealth Management Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 745 shares — an estimated $576K sold.

Redwood Wealth Management Group first reported a position in REGN in Q1 2023 and held it in 13 quarters. The position peaked at $583K in Q4 2025. 625 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Redwood Wealth Management Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Redwood Wealth Management Group sold 745 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $576K.
Redwood Wealth Management Group first reported a position in Regeneron Pharmaceuticals in Q1 2023 and held it in 13 quarters.
Redwood Wealth Management Group's Regeneron Pharmaceuticals position peaked at $583K in Q4 2025.
625 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Redwood Wealth Management Group's 13F filing for Q2 2026.